Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DR. REDDYS LAB LUPIN/
DR. REDDYS LAB
 
P/E (TTM) x 40.7 19.7 206.7% View Chart
P/BV x 6.0 4.4 134.9% View Chart
Dividend Yield % 0.2 0.6 38.0%  

Financials

 LUPIN   DR. REDDYS LAB
EQUITY SHARE DATA
    LUPIN
Mar-23
DR. REDDYS LAB
Mar-23
LUPIN/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs7994,656 17.2%   
Low Rs5833,788 15.4%   
Sales per share (Unadj.) Rs365.81,481.4 24.7%  
Earnings per share (Unadj.) Rs9.8270.7 3.6%  
Cash flow per share (Unadj.) Rs29.2345.7 8.4%  
Dividends per share (Unadj.) Rs4.0040.00 10.0%  
Avg Dividend yield %0.60.9 61.1%  
Book value per share (Unadj.) Rs270.71,389.6 19.5%  
Shares outstanding (eoy) m454.98166.53 273.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.92.8 66.3%   
Avg P/E ratio x70.215.6 450.2%  
P/CF ratio (eoy) x23.712.2 193.8%  
Price / Book Value ratio x2.63.0 84.0%  
Dividend payout %40.714.8 275.1%   
Avg Mkt Cap Rs m314,381703,039 44.7%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87246,466 66.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,417246,697 67.5%  
Other income Rs m1,50910,555 14.3%   
Total revenues Rs m167,926257,252 65.3%   
Gross profit Rs m17,20663,860 26.9%  
Depreciation Rs m8,80712,502 70.4%   
Interest Rs m2,7431,428 192.1%   
Profit before tax Rs m7,16560,485 11.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,68815,412 17.4%   
Profit after tax Rs m4,47745,073 9.9%  
Gross profit margin %10.325.9 39.9%  
Effective tax rate %37.525.5 147.2%   
Net profit margin %2.718.3 14.7%  
BALANCE SHEET DATA
Current assets Rs m124,513203,161 61.3%   
Current liabilities Rs m92,65485,721 108.1%   
Net working cap to sales %19.147.6 40.2%  
Current ratio x1.32.4 56.7%  
Inventory Days Days2679 33.1%  
Debtors Days Days98107 91.6%  
Net fixed assets Rs m103,490112,638 91.9%   
Share capital Rs m910833 109.2%   
"Free" reserves Rs m122,246230,571 53.0%   
Net worth Rs m123,156231,404 53.2%   
Long term debt Rs m2751,278 21.5%   
Total assets Rs m228,003315,799 72.2%  
Interest coverage x3.643.4 8.3%   
Debt to equity ratio x00 40.4%  
Sales to assets ratio x0.70.8 93.4%   
Return on assets %3.214.7 21.5%  
Return on equity %3.619.5 18.7%  
Return on capital %8.026.6 30.2%  
Exports to sales %052.2 0.0%   
Imports to sales %016.8 0.0%   
Exports (fob) Rs mNA128,803 0.0%   
Imports (cif) Rs mNA41,484 0.0%   
Fx inflow Rs m48,057128,803 37.3%   
Fx outflow Rs m21,75241,484 52.4%   
Net fx Rs m26,30687,319 30.1%   
CASH FLOW
From Operations Rs m18,97258,875 32.2%  
From Investments Rs m-12,868-41,373 31.1%  
From Financial Activity Rs m-3,373-26,861 12.6%  
Net Cashflow Rs m2,732-9,073 -30.1%  

Share Holding

Indian Promoters % 46.8 26.7 175.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 47.3 97.0%  
FIIs % 16.1 28.6 56.3%  
ADR/GDR % 0.0 15.3 -  
Free float % 53.0 58.0 91.3%  
Shareholders   281,542 257,794 109.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Lupin vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Dr. Reddys Share Price Performance

Period Lupin Dr. Reddys S&P BSE HEALTHCARE
1-Day 1.23% 1.78% 1.18%
1-Month 0.15% -4.23% -0.75%
1-Year 151.14% 35.93% 61.82%
3-Year CAGR 17.13% 10.85% 18.16%
5-Year CAGR 17.42% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Lupin, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.